Skip NavigationSkip to Content

Inhibition of thrombin-induced platelet aggregation using human single-chain Fv antibodies specific for TREM-like transcript-I

  1. Author:
    Giomarelli, B.
    Washington, V. A.
    Chisholm, M. M.
    Quigley, L.
    McMahon, J. B.
    Mori, T.
    McVicar, D. W.
  2. Author Address

    NCI, Mol Targets Dev Program, Frederick, MD 21702 USA. NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA. Univ Cent Caribe, Dept Anat & Cell Biol, Bayamon, PR USA.;McVicar, DW, NCI, Mol Targets Dev Program, 560 Rm 31-46, Frederick, MD 21702 USA.;McvicarD@mail.nih.gov
    1. Year: 2007
    2. Date: Jun
  1. Journal: Thrombosis and Haemostasis
    1. 97
    2. 6
    3. Pages: 955-964
  2. Type of Article: Article
  3. ISSN: 0340-6245
  1. Abstract:

    TREM-like transcript-1 (TLT-1) is a novel platelet membrane receptor, which has been recently characterized in mice.TLT-1 is expressed exclusively in platelets and megakaryocytes, and its expression is dramatically upregulated upon platelet activation, suggesting that it plays a unique role in hemostasis and/or thrombosis. In this study we identified and characterized highly specific human monoclonal antibodies that bind to TLT-1 by screening a naive library of single chain Fv fragments (scFvs) displayed on filamentous phage (Thomlinson I library).These scFvs detected plate-bound TLT-1, captured soluble TLT-1, and readily reacted with cell-bound TLT-1 on transfectants and primary human platelets. Most importantly, anti-TLT-1 scFvs inhibited thrombin-mediated human platelet aggregation. This inhibition was specific for thrombin-induced aggregation and was reversible with higher doses of agonist.These data are the first to demonstrate a biological role for TLT-1 and its potential as a therapeutic target.The human scFvs isolated in this study may represent novel anti-platelet therapeutic agents.

    See More

External Sources

  1. DOI: 10.1160/th06-08-0456
  2. WOS: 000247309000013

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel